Residency program marks new partnership with Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy

Translate to Spanish or other 102 languages!

Pictured L-R: Israel Rocha Jr., Chief Executive Officer, DHR; Linda Resendez, Vice President, Clinical Integration, DHR; Indra K. Reddy, Ph.D., Professor and Founding Dean, Texas A&M Rangel College of Pharmacy; Senator Juan “Chuy” Hinojosa; Dr. Ron Ozuna, Pharm.D., BCPS, Clinical Coordinator, Pharmacy, DHR; and Diego Garza, 2014 Pharm. D. Candidate, Texas A&M Rangel College of Pharmacy.
Pictured L-R: Israel Rocha Jr., Chief Executive Officer, DHR; Linda Resendez, Vice President, Clinical Integration, DHR; Indra K. Reddy, Ph.D., Professor and Founding Dean, Texas A&M Rangel College of Pharmacy; Senator Juan “Chuy” Hinojosa; Dr. Ron Ozuna, Pharm.D., BCPS, Clinical Coordinator, Pharmacy, DHR; and Diego Garza, 2014 Pharm. D. Candidate, Texas A&M Rangel College of Pharmacy.

Mega Doctor News

- Advertisement -

EDINBURG, Texas — Doctors Hospital at Renaissance (DHR) today announced creation of the Rio Grande Valley’s first co-funded Pharmacy Residency program aimed at recruiting the best and brightest pharmacy graduates to continue bringing the best patient care to the area.

“Pharmacists are an essential component of patient care. Without them, medical treatment would be inefficient and at many times, ineffective,” said Carlos Cardenas, M.D., DHR chairman of the board.

The program, a partnership with the Texas A&M Irma Lerma Rangel College of Pharmacy, will expand the hospital’s clinical team by two faculty pharmacists who are set to begin training the first pharmacy resident in 2015.

- Advertisement -

“Doctors Hospital at Renaissance recognizes the need for quality pharmacists to work alongside physicians to provide superior medical care to our patients and community,” said Israel Rocha Jr., DHR chief executive officer. “The new program will be an invaluable asset to our hospital, patients, and community by enabling DHR to provide an even greater quality of care to our patients.”

Addition of the program will allow for creation of medication therapy management clinics aimed at extending DHR’s pharmacy and patient care services. The clinics will bolster efforts to ensure that patients are administered the correct medication regimen, understand the importance of their medications, and receive thorough education on proper adherence. When patients have questions and concerns about their medications the clinics will serve as a resource for clarification to help maintain medication adherence and better outcomes.

“Proactive initiatives like this can help reduce unnecessary readmissions, ensure patient safety, and advance patient education at DHR and the larger community in the RGV,” Rocha said.

The program will also create opportunity for additional community service and public health activities, such as immunization drives, health screenings, drug take-back days, and health fairs.

- Advertisement -

The Texas A&M Rangel College of Pharmacy in Kingsville, ranked as a top-50 pharmacy school by U.S. News & World Report, was founded in 2006 in response to the shortage of pharmacists in the border region. Eighty six students will graduate this month with 23 percent entering residency programs across the nation, a rate higher than the national average. More than 30 percent of the college’s graduates remain in South Texas to practice, 60 percent of who work in underserved areas. MDN

 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Cybersecurity Alert as Hackers Exploit Computer and Smartphone Vulnerabilities

Federal cybersecurity authorities are urging computer and smartphone users to keep their devices updated following reports of actively exploited security vulnerabilities affecting Apple products and Google’s Chrome browse

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

DHR Health and RGV College Celebrate Fifth Nursing Apprenticeship Graduating Class

DHR Health and Rio Grande Valley College celebrated the fifth graduating class of their Registered Nurse Apprenticeship Program on September 3, 2026, at the Edinburg Conference Center at Renaissance, marking a milestone for an initiative designed to help working nurses advance their careers

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 
- Advertisement -